Chicago Atlantic BDC Inc

Análisis de la acción Chicago Atlantic BDC Inc (LIEN)

$9.200

+0.101 (+1.10%)Al cierre

Loading chart…
Máximo
9.250
Apertura
9.110
Precio medio ponderado por volumen
9.19
Volumen
17.50K
Capitalización
—
Mínimo
9.110
Importe
160.80K
EV/EBITDA, TTM
-0.23

Chicago Atlantic BDC, Inc. is a specialty finance company. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies in the health and wellness sector. It has typically invested in and expects to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies. Its business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. The Company may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities. The Company is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis and other niche or underfollowed sectors.

Análisis de IA of Chicago Atlantic BDC Inc (LIEN)

Mantener

While LIEN has a strong dividend yield of 13.19% and a forward P/E ratio of 5.58, indicating potential value, the stock has underperformed with a year-to-date change of -11.98% and a recent RSI of 42.22, suggesting it is nearing oversold territory but not yet a strong buy signal. The main risk is the recent decline in net income to common shareholders, which dropped to $6,064,079 in Q2 2026 from $8,534,388 in Q1 2026, indicating potential profitability concerns.

Métricas de valoración

El PER previsto actual de Chicago Atlantic BDC Inc (LIEN) es 5.61, frente a su media de 5 años de 6.58.

PER previsto

Infravalorado
Media 5A P/E
6.58
P/E actual
5.61
Sobrevalorada
7.18
Infravalorada
5.98

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
84.70
EV/EBITDA actual
-0.23
Sobrevalorada
282.91
Infravalorada
-113.51

Precio/ventas previsto

Infravalorado
Media 5A P/S
3.32
P/S actual
3.07
Sobrevalorada
3.53
Infravalorada
3.12

Escenarios de precio de Alphio AI para LIEN

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%LIEN

$10.25

Precio del escenario

B

Base

Base · 50%LIEN

$9.62

Precio del escenario

B

Bajista

Bajista · 25%LIEN

$7.94

Precio del escenario

Cronología de eventos

2026-05-11 (ET)

16:20:00

Chicago Atlantic BDC Files for $500M Securities Registration

2026-03-19 (ET)

07:10:00

Chicago Atlantic BDC Reports $14.2M Investment Income

2025-11-13 (ET)

07:15:20

Chicago Atlantic BDC Announces Q3 NII per Share of 42 Cents, Up from 34 Cents Last Quarter

2025-08-14 (ET)

07:07:36

Chicago Atlantic BDC reports Q2 NII 34c vs. 38c last year

2025-05-14 (ET)

07:14:32

Chicago Atlantic BDC reports Q1 EPS 33c vs 35c last year

Noticias

Preguntas frecuentes sobre LIEN, respondidas por Alphio AI

Chicago Atlantic BDC, Inc. is a specialty finance company. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies in the health and wellness sector. It has typically invested in and expects to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies. Its business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. The Company may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities. The Company is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis and other niche or underfollowed sectors. It operates in the Financials sector.

While LIEN has a strong dividend yield of 13.19% and a forward P/E ratio of 5.58, indicating potential value, the stock has underperformed with a year-to-date change of -11.98% and a recent RSI of 42.22, suggesting it is nearing oversold territory but not yet a strong buy signal. The main risk is the recent decline in net income to common shareholders, which dropped to $6,064,079 in Q2 2026 from $8,534,388 in Q1 2026, indicating potential profitability concerns.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar